Sharecast News
07 Apr, 2021 16:26 07 Apr, 2021 16:26

EU regulator to investigate ethical standards of Sputnik V trials

ep archivo - vacuna frente a la covid-19
ALVARO CALVO - Archivo

The European Medicines Agency will launch an investigation next week into the ethical standards of the clinical trials for the Russian Sputnik V jab against the novel coronavirus.

Sources told the Financial Times that the EU regulator was concerned about whether the clinical tests had contravened ethical rules. The sources said there were worries regarding a lack of "good clinical practice".

Covid-19 vaccine trials involved Russian military servicemen and state employees. In an earlier report by Reuters, there were allegations that some of the people involved in the tests had been pressured into participating.

The Russian Direct Investment Fund (the Kremlin’s sovereign wealth fund) that is behind the development of the vaccine denied such claims.

An official ruling hasn't been issued by the EMA yet on whether the Russian jab is acceptable for use in the EU.

Yet some countries, such as Hungary and Slovakia, have already granted emergency approval.

Moscow offered Sputnik V as a solution to the EU’s recent vaccine supply troubles, but EU commissioner Thierry Breton said that there was no need for the Russian jab.

That move sparked criticism from the Kremlin that accused the EU of biased prejudice against its state vaccine.


News Source: © 2021 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.